Page last updated: 2024-11-05

clobutinol

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Clobutinol is a synthetic antitussive drug with a central action. It is a derivative of benzydamine, a non-steroidal anti-inflammatory drug. Clobutinol has been shown to inhibit the cough reflex by acting on the central nervous system. Its mechanism of action is not fully understood but is thought to involve the suppression of the cough center in the medulla oblongata. Clobutinol has also been reported to have some analgesic and anti-inflammatory properties. It is used to treat coughs of various origins, including coughs associated with the common cold, bronchitis, and asthma. Clobutinol is available in various forms, including tablets, capsules, syrups, and oral solutions. It is generally well-tolerated, but side effects such as drowsiness, dizziness, and nausea may occur. Clobutinol is not recommended for use during pregnancy or breastfeeding. The drug is usually taken orally, and the dosage is determined by the severity of the cough and the patient's age. Clobutinol is also being investigated for its potential therapeutic effects in other conditions, such as irritable bowel syndrome and chronic obstructive pulmonary disease.'

clobutinol: was minor as SILOMAT mapped to AMINO ALCOHOLS (63-79) [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID26937
CHEMBL ID1474889
CHEBI ID94381
SCHEMBL ID148543
MeSH IDM0067642

Synonyms (53)

Synonym
1-(4-chlorophenyl)-4-(dimethylamino)-2,3-dimethylbutan-2-ol
14860-49-2
iversal
p-cloro-alpha-(2-(dimetilamino)-1-metiletil)-alpha-metil fenetil alcool [italian]
clobutinolum [inn-latin]
p-chloro-alpha-(2-(dimethylamino)-1-methylethyl)-alpha-methyl-phenethyl alcohol
brn 2843490
phenethyl alcohol, p-chloro-alpha-(2-(dimethylamino)-1-methylethyl)-alpha-methyl-
clobutinol [inn]
4-chloro-alpha(2-(dimethylamino)-1-methylethyl)alpha-methylbenzeneethanol
1-(4-chlorophenyl)-2,3-dimethyl-4-dimethylamino-2-butanol
benzeneethanol, 4-chloro-alpha-(2-(dimethylamino)-1-methylethyl)-alpha-methyl-
benzeneethanol, 4-chloro-alpha-(2-(dimethylamino)-1-methyl)-alpha-methyl-
p-chloro-alpha-(2-(dimethylamino)-1-methylethyl)-alpha-methylphenethyl alcohol
einecs 238-926-4
c14h22clno
clobutinol
iversal (tn)
clobutinol (inn)
D07716
NCGC00159437-02
CHEMBL1474889
kat 256 [as hydrochloride]
r05db03
1ny2ix043a ,
unii-1ny2ix043a
p-cloro-alpha-(2-(dimetilamino)-1-metiletil)-alpha-metil fenetil alcool
clobutinolum
BRD-A43809092-003-01-3
SCHEMBL148543
p-chloro-.alpha.-(2-(dimethylamino)-1-methylethyl)-.alpha.-methylphenethyl alcohol
clobutinol [who-dd]
kat 256 free base
kat-256 free base
benzeneethanol, 4-chloro-.alpha.-(2-(dimethylamino)-1-methylethyl)-.alpha.-methyl-
clobutinol [mi]
p-cloro-.alpha.-(2-(dimetilamino)-1-metiletil)-.alpha.-metil fenetil alcool
KVHHQGIIZCJATJ-UHFFFAOYSA-N
phenethyl alcohol, p-chloro-.alpha.-[2-(dimethylamino)-1-methylethyl]-.alpha.-methyl-
benzeneethanol, 4-chloro-.alpha.-(2-(dimethylamino)-1-methyl)-.alpha.-methyl-
benzeneethanol, 4-chloro-.alpha.-[2-(dimethylamino)-1-methylethyl]-.alpha.-methyl-
p-chloro-.alpha.-(2-(dimethylamino)-1-methylethyl)-.alpha.-methyl-phenethyl alcohol
p-chloro-.alpha.-[2-(dimethylamino)-1-methylethyl]-.alpha.-methylphenyl alcohol
DTXSID2022838
DB09004
1-(4-chlorophenyl)-4-(dimethylamino)-2,3-dimethyl-2-butanol
CHEBI:94381
diethylenetriamine crosslinked with epichlorohydrin
(2s)-1-(4-chlorophenyl)-4-(dimethylamino)-2,3-dimethylbutan-2-ol
Q415654
FT-0714887
CS-0613654
HY-148144

Research Excerpts

Effects

ExcerptReferenceRelevance
"Clobutinol has been clinically reported to induce long QT syndrome. "( Clobutinol delays ventricular repolarization in the guinea pig heart: comparison with cardiac effects of HERG K+ channel inhibitor E-4031.
Nakamura, M; Namekata, I; Sakurai, Y; Sasaki, R; Sendo, A; Takahara, A; Tanaka, H, 2009
)
3.24
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (2)

ClassDescription
organic amino compoundA compound formally derived from ammonia by replacing one, two or three hydrogen atoms by organyl groups.
benzenesAny benzenoid aromatic compound consisting of the benzene skeleton and its substituted derivatives.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (3)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Microtubule-associated protein tauHomo sapiens (human)Potency39.81070.180013.557439.8107AID1468
aldehyde dehydrogenase 1 family, member A1Homo sapiens (human)Potency0.14990.011212.4002100.0000AID1030
lamin isoform A-delta10Homo sapiens (human)Potency35.48130.891312.067628.1838AID1487
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (2)

Assay IDTitleYearJournalArticle
AID504749qHTS profiling for inhibitors of Plasmodium falciparum proliferation2011Science (New York, N.Y.), Aug-05, Volume: 333, Issue:6043
Chemical genomic profiling for antimalarial therapies, response signatures, and molecular targets.
AID588220Literature-mined public compounds from Kruhlak et al phospholipidosis modelling dataset2008Toxicology mechanisms and methods, , Volume: 18, Issue:2-3
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (34)

TimeframeStudies, This Drug (%)All Drugs %
pre-199022 (64.71)18.7374
1990's2 (5.88)18.2507
2000's7 (20.59)29.6817
2010's3 (8.82)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 54.13

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index54.13 (24.57)
Research Supply Index3.71 (2.92)
Research Growth Index4.63 (4.65)
Search Engine Demand Index83.53 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (54.13)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials2 (5.26%)5.53%
Reviews0 (0.00%)6.00%
Case Studies5 (13.16%)4.05%
Observational0 (0.00%)0.25%
Other31 (81.58%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]